Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-05-12 / Virol. J. 2014 May;11:84Current status of oncothermia therapy for lung cancer
/in Hyperthermia, International Publications, NSCLC /von 2014-04-10 / Korean J Thorac Cardiovasc Surg 2014 Apr;47(2):77-93Immunotherapy prospects in the treatment of lung cancer and mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45Immunotherapy in lung cancer
/in International Publications, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63Immunotherapy and lung cancer: current developments and novel targeted therapies
/in Dendritic Cells, International Publications, NSCLC /von 2014-01-01 / Immunotherapy 2014;6(11):1221-35Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
/in Dendritic Cells, International Publications, NSCLC /von 2013-11-05 / Autoimmunity 2014 Feb;47(1):46-56Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2013-08-13 / Cryobiology 2013 Oct;67(2):235-40Impact of dendritic cells combining with cytokine-induced killer cells synergized chemotherapy in patients of advanced non-small cell lung cancer.
/in Dendritic Cells, NSCLC /von 2013-05-31 / J Clin Oncol 31, 2013 (suppl; abstr e19018)Harnessing the immune system for the treatment of non-small-cell lung cancer
/in International Publications, NSCLC /von 2013-02-11 / J. Clin. Oncol. 2013 Mar;31(8):1021-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de